ReViral’s RV521 fusion inhibitor produces highly significant reduction in viral load and clinical symptoms
Healthcare
Wed, 31/01/2018 - 16:30
London, UK, 31st January 2018 / Sciad Newswire / 2018 will be a transformative year for UK healthcare as pioneering genomics companies identify people’s risk of d
Wed, 24/01/2018 - 07:30
London, UK, 24th January 2018 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, announced
Wed, 17/01/2018 - 07:30
Company establishes U.S. subsidiary to expand operations
Wed, 03/01/2018 - 11:30
Flanders, Belgium, 3rd January 2018 / Sciad Newswire / Bruges, Belgium will host the third edition of
Thu, 14/12/2017 - 07:30
London, UK, 14th December 2017 / Sciad Newswire / ‘Trends and truth in life science investment’ is the latest annual report, published by
Wed, 13/12/2017 - 10:00
13th December 2017 / Sciad Newswire / Amyndas Pharmaceuticals, which is committed to developing innovative therapeutics for
Tue, 28/11/2017 - 07:30
London, UK, 28th November 2017 / Sciad Newswire / The RSA Group, the leading global Life Sciences executive search firm,
Tue, 28/11/2017 - 07:00
Edinburgh, UK, 28th November 2017 / Sciad Newswire / Synpromics Ltd is pleased to announce a new collaboration with UCL to
Thu, 23/11/2017 - 14:14
Dublin, Ireland, 23rd November 2017 / Sciad Newswire / Inflection Biosciences Ltd, a private company developing innova